Gradient Denervation Technologies
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.
Gradient Denervation Technologies operates in biotechnology, medical device based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2019.
The company sits in the biotechnology, medical device segment, where it competes on its core product or service.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Series_A.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $14M.
| Sector | Biotechnology, Medical Device |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $14,000,000 |
Website: www.gradientdenervation.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account